MGX
Metagenomi Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Metagenomi Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Metagenomi Therapeutics, Inc.
0.80
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Vanguard Capital ManagementVanguardindex-like | $1.3M | 17.41% | +1.87% | |
| 2 | Renaissance TechnologiesRenaissance Technologies | $883,456 | 11.99% | −5.77% | |
| 3 | Catalio Capital ManagementCatalio | $629,502 | 8.54% | 0.00% | |
| 4 | Peapod Lane CapitalPeapod Lane Capital | $624,779 | 8.48% | +1.60% | |
| 5 | Two Sigma InvestmentsTwo Sigma | $611,304 | 8.30% | +3.41% | |
| 6 | Bridgeway Capital ManagementBridgeway | $476,357 | 6.47% | +1.14% | |
| 7 | Wells FargoWells Fargo | $451,614 | 6.13% | +87.75% | |
| 8 | Geode Capital ManagementGeodeindex-like | $343,672 | 4.67% | −19.41% | |
| 9 | Pura Vida InvestmentsPura Vida | $314,625 | 4.27% | 0.00% | |
| 10 | BlackRockBlackRockindex-like | $306,581 | 4.16% | +11.95% | |
| 11 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $203,789 | 2.77% | +0.63% | |
| 12 | Jacobs Levy Equity ManagementJacobs Levy Equity | $190,400 | 2.58% | −58.13% | |
| 13 | State StreetState Streetindex-like | $142,622 | 1.94% | −0.48% | |
| 14 | Millennium ManagementMillennium | $135,690 | 1.84% | −32.97% | |
| 15 | Man GroupMan | $129,865 | 1.76% | +38.78% | |
| 16 | Resolute AdvisorsResolute | $107,033 | 1.45% | 0.00% | |
| 17 | Northern TrustNorthern Trustindex-like | $82,036 | 1.11% | −8.29% | |
| 18 | RBF CapitalRBF Capital | $76,185 | 1.03% | 0.00% | |
| 19 | XTX TopcoXTX Topco | $66,291 | 0.90% | +37.27% | |
| 20 | BBR PartnersBBR Partners | $63,550 | 0.86% | 0.00% | |
| 21 | Jane Street GroupJane Street | $45,691 | 0.62% | −74.65% | |
| 22 | Fortitude Advisory GroupFortitude Advisory | $44,256 | 0.60% | 0.00% | |
| 23 | Citadel AdvisorsCitadel | $21,243 | 0.29% | +5.05% | |
| 24 | Qube Research & TechnologiesQube Research & Technologies | $20,052 | 0.27% | new | |
| 25 | UBS GroupUBS | $18,794 | 0.26% | −1.89% |
41 managers report $7.4M of Metagenomi Therapeutics on form 13F for the quarter ended Jun 30 '26. 10 of them hold 80% of it; Vanguard is largest at 17.41%.
Linked news
NewsExpected move
No implied move.
No implied move.
No implied move.